European Medicines Agency Committee Decides Popular Weight-Loss Drug Safe from Suicide Risk

Friday, 12 April 2024, 11:11

The European Medicines Agency committee affirmed that a widely-used weight-loss medication poses no enhanced risk of suicide. Thus, easing concerns regarding the drug's safety and efficacy for consumers.
https://store.livarava.com/a4382ef9-f8bd-11ee-a6be-63e1980711b2.jpg
European Medicines Agency Committee Decides Popular Weight-Loss Drug Safe from Suicide Risk

EU stands by safety of weight-loss drug

A recent decision by the European Medicines Agency's committee reassured the public that a widely used weight-loss drug does not increase the risk of suicide. This conclusion addresses concerns regarding the drug's potential risks on mental health and overall well-being.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe